World health organizations are calling for enhanced support for diagnostics after the declaration last week of a global public health emergency caused by the clade 1 #mpox variant. We're proud to provide armored molecular controls for MDx development, as well as controls, calibrators & calibration verifiers for clinical laboratory and point-of-care testing. 📰 Read about the need for accelerated development & assessment of rapid molecular tests capable of detecting both clades I and II: https://lnkd.in/g7XiUNAg 💡 Learn more about our range of diagnostics products: https://lnkd.in/gnnBYDeT #diagnostics #MDx #controls #infectiousdiseases #lablife #clinicalresearch
Asuragen, a Bio-Techne brand
Biotechnology
Austin, Texas 10,168 followers
People Deserve Better Answers
About us
Asuragen a Bio-Techne brand is a molecular diagnostic product company changing the way patients are treated in genetics and oncology. Asuragen’s diagnostic systems, composed of proprietary chemistry and software, deliver powerful answers using broadly installed instrument platforms. They are simple to adopt and expand the ability to serve patients. Asuragen is a product foundry rapidly and efficiently addressing current and emerging clinical needs, including cancer diagnosis and monitoring, reproductive health and aging, serving laboratories across a patient’s lifespan with its best in class diagnostic tests. Bio-Techne a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities.
- Website
-
http://www.asuragen.com
External link for Asuragen, a Bio-Techne brand
- Industry
- Biotechnology
- Company size
- 51-200 employees
- Headquarters
- Austin, Texas
- Type
- Privately Held
- Founded
- 2006
- Specialties
- Oncology, Genetics, molecular diagnostics, genetics testing, rare disease testing, and armored rna
Locations
-
Primary
2150 Woodward St.
Suite 100
Austin, Texas 78744, US
Employees at Asuragen, a Bio-Techne brand
Updates
-
Meet with our team at #WorldCDx24 next week! Don't forget to check out our exclusive presentation by SVP & General Manager Bernard Andruss on Wednesday. #CDx #companiondiagnostics #regulatorystrategies #pharma #diagnostics #MDx #drugdiscovery #drugdevelopment
Heading to #WorldCDx 2024? Let’s meet! Stop by Bio-Techne’s booth to learn more about our #CDx services and join us for an exclusive presentation given by Bio-Techne SVP & General Manager Bernard Andruss on Wednesday, September 4th at 4:10pm. Topics will cover technical & platform considerations, regulatory strategies, commercial considerations, and more. Learn more about our presence at the show: https://bit.ly/4dQBxGy
-
Let's have a discussion! What are some of the biggest hurdles your lab faces today? Feel free to drop your experiences in the comments! #biotech #healthcare #discussion #solutions #genetics #oncology #diagnostics #moleculardiagnostics #carrierscreening
This content isn’t available here
Access this content and more in the LinkedIn app
-
Labs are facing challenges as carrier screening guidelines evolve to incorporate broader range of genes. While short-read sequencing works fine for many genes, long-read sequencing can provide deeper insight into the most complex genes. Long-read sequencing facilitates covering numerous challenging genes with greater insight while reducing complexity of maintaining multiple workflows. With affordable nanopore-based sequencing, capital expenditures need not be a concern for clinical labs. Ninad Pendse, Senior Product Manager at Asuragen, shared insights on adapting to today's testing landscape in this Diagnostics World article: https://bit.ly/4dT9SVu #CarrierScreening #SequencingTechnologies #LongReadSequencing #PrecisionMedicine #CarrierScreeningResearch #Nanopore #Diagnostics #MolecularDiagnostics #MDx
-
On #WomensEqualityDay, we celebrate one of our favorite women from #herstory: Hertha Ayrton, a pioneering suffragette scientist. Read about her incredible life in this PHYSICSworld story by Anita Chandran and get inspired! #GenderEquality https://bit.ly/46YaeIu
Hertha Ayrton: pioneering inventor and suffragette – Physics World
https://physicsworld.com
-
That's a wrap on the 2024 Asuragen sales meeting! Our theme of "building a legacy, thriving together" captured our commitment to creating products that improve lives as well as the importance of teamwork and collaboration. Throughout the week we celebrated the past year’s successes, learned from one another, and of course enjoyed the time together! Stay tuned to see what's next for Asuragen as we continue to pave the way for transformative developments in the industry. https://asuragen.com/ #salesmeeting #diagnostics #teamculture #genetics #oncology
-
-
According to European Alliance for Newborn Screening for Spinal Muscular Atrophy, 66% of the babies born in the EU are screened for SMA and more than 72% of European newborns including Russia and Turkey are screened. Check out how we strive to make a difference in people with SMA, identified via newborn screening, and in the carrier screening space as well: https://bit.ly/3MekVwM #Asuragen #BioTechne #SMA #NBS #SMAEurope #PCR #nanopore #newborn #diagnostics #carrierscreening #SMAAwarenessMonth #NewbornScreening
-
#DYK: mosquito-borne diseases infect up to 700m ppl each year, killing >1m? We're here to help create a world free from the fear & suffering caused by mosquito-borne diseases. Learn more about our Armored RNA Quant Pentavalent Arbovirus Control, which targets regions of the #Chikungunya, #Dengue, #WestNile, #YellowFever & #Zika viruses. #WorldMosquitoDay https://bit.ly/4dkeXGu
-
-
Been curious about when our targeted nanopore sequencing-based #carrierscreening assay might become available for research use only? So was GenomeWeb. See what Asuragen CSO Brian Haynes had to say about the progress we've made on the AmplideX Nanopore Carrier Plus kit. https://bit.ly/4fSouqe Oxford Nanopore Technologies
Asuragen Makes Strides Developing Nanopore Sequencing-Based Carrier Screening Assay
genomeweb.com
-
Did you know that Asuragen's AmplideX PCR/CE workflow not only covers FMR1 repeats but also other repeat disorder genes, copy number assays, and highly multiplexed variant detection? Watch the webinar to hear from a lab that adopted the AmplideX SMN1/2 Plus Kit for detection of SMN1 and SMN2 copy numbers and genetic variants. #sma #spinalmuscularatrophy #SMAawarenessmonth #FragileX #FMR1 #genetictesting #ResearchUseOnly https://lnkd.in/gsYmi6TK
AmplideX® to the Rescue: Asuragen's AMP 2023 Coporate Workshop
https://www.youtube.com/